We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panels Recommend Removal of Black Box Label for Pfizer’s Chantix
FDA Panels Recommend Removal of Black Box Label for Pfizer’s Chantix
Two FDA advisory committees backed the removal of a black box label for Pfizer’s smoking cessation drug Chantix, citing the therapy’s risk-benefit ratio.